南美洲和中美洲多发性硬化症治疗市场预测至 2027 年 - COVID-19 影响和按药物类别（免疫抑制剂和免疫调节剂）、给药途径（注射和口服）和分销渠道（医院药房、零售药房和电子渠道）进行的区域分析商业）
No. of Pages: 119 | Report Code: TIPRE00022637 | Category: Life Sciences
No. of Pages: 119 | Report Code: TIPRE00022637 | Category: Life Sciences
多发性硬化症（MS）是一种影响中枢神经系统的自身免疫性疾病。多发性硬化症是一种广泛存在的致残性神经系统疾病，大多数在 20-50 岁年龄段的人群中被诊断出来。这是一种潜在的使人衰弱的疾病，会导致身体的沟通和协调功能中断。
南美洲和中美洲多发性硬化症治疗市场预计将从2019年的10.0982亿美元增至2027年的15.1403亿美元；预计 2020 年至 2027 年复合年增长率为 6.5%。市场的增长归因于几个关键驱动因素，例如人口中多发性硬化症患病率的增加以及多发性硬化症研究资金的增加。然而，多发性硬化症治疗的高昂费用阻碍了市场的增长。
根据巴西神经病学大会发表的研究，2020年，多发性硬化症的平均患病率多发性硬化症患病率为 8.69/100,000 居民。因此，多发性硬化症患病率的不断上升推动了南美洲和中美洲多发性硬化症治疗市场的增长。由于整个拉丁美洲的资金增加，人们正在开展广泛的研究，开发针对多发性硬化症的新药物和治疗方法，以及识别多发性硬化症潜在原因的其他方法。美国国家神经疾病和中风研究所、国家多发性硬化症协会和帕金森行动网络等各种组织正在开展广泛的努力，为多发性硬化症创造新的疗法，这正在推动市场的增长。
南美洲和中美洲的 COVID-19 病例数量不断增加。目前，该地区各国正在迅速增加抗击COVID-19疫情的临床项目。然而，关于新型冠状病毒对多发性硬化症影响的研究可能会对南美洲和中美洲多发性硬化症治疗市场的增长产生负面影响。例如，一项题为“估计阿根廷布宜诺斯艾利斯多发性硬化症患者感染 COVID-19 的风险”的研究表明，是在阿根廷布宜诺斯艾利斯中心进行的。随着该地区 COVID-19 患者数量呈指数级增长，越来越需要显示新型冠状病毒对 MS 影响的数据。
按药物类别划分，南美洲和中美洲多发性硬化症治疗市场是分为免疫抑制剂和免疫调节剂。免疫调节剂细分市场在 2019 年占据了较大的市场份额，而免疫抑制剂细分市场预计在预测期内的市场复合年增长率更高。
南部和中部地区美国多发性硬化症治疗市场按给药途径分为注射剂和口服剂。注射剂细分市场在 2019 年占据了更大的市场份额，预计该细分市场在预测期内的市场复合年增长率将更高。
基于分销渠道南美洲和中美洲多发性硬化症治疗市场分为医院药房、零售药房和电子商务。医院药房细分市场在 2019 年占据最大市场份额，而电子商务细分市场预计在预测期内的复合年增长率最高。
;
一些与这份关于南美洲和中美洲多发性硬化症治疗市场报告相关的主要和次要来源是巴西神经病学大会、疾病控制和预防中心 (CDC)、国家多发性硬化症协会和美国多发性硬化症协会 (MSAA)。
Strategic insights for South and Central America Multiple Sclerosis Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,009.82 Million |
| Market Size by 2027 | US$ 1,514.03 Million |
| Global CAGR (2020 - 2027) | 6.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 药物类别
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South and Central America Multiple Sclerosis Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Multiple Sclerosis Therapeutics Market is valued at US$ 1,009.82 Million in 2019, it is projected to reach US$ 1,514.03 Million by 2027.
As per our report South and Central America Multiple Sclerosis Therapeutics Market, the market size is valued at US$ 1,009.82 Million in 2019, projecting it to reach US$ 1,514.03 Million by 2027. This translates to a CAGR of approximately 6.5% during the forecast period.
The South and Central America Multiple Sclerosis Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Multiple Sclerosis Therapeutics Market report:
The South and Central America Multiple Sclerosis Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Multiple Sclerosis Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Multiple Sclerosis Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Multiple Sclerosis Therapeutics Market
